Algeria Eliminates Trachoma as a Public Health Problem

Why It Matters

Algeria’s success proves that sustained political commitment and integrated health interventions can eradicate a neglected tropical disease, delivering lasting eye‑health benefits and economic gains for vulnerable communities.

Key Takeaways

• Algeria becomes 10th African nation to eliminate trachoma
• WHO validated elimination after 2022 surveys met thresholds
• SAFE strategy combined surgery, antibiotics, hygiene, water access
• Three southern wilayas required door‑to‑door TT screening
• Post‑validation surveillance mandated to prevent disease resurgence

Pulse Analysis

Trachoma remains the world’s leading infectious cause of blindness, affecting roughly 1.9 million people and putting 97 million at risk in endemic regions. The disease’s burden is concentrated in low‑income, tropical settings, where limited water, sanitation, and health infrastructure exacerbate transmission. The WHO’s roadmap for neglected tropical diseases (2021‑2030) sets elimination targets that, when met, can dramatically reduce visual impairment and its associated socioeconomic costs. Algeria’s validation underscores how meeting these global goals is feasible with coordinated action.

Algeria’s journey began over a century ago with the establishment of the Pasteur Institute and intensified after independence through a free‑public‑health system. The country adopted the SAFE framework—Surgery, Antibiotics, Facial cleanliness, and Environmental improvement—tailoring it to local needs. A three‑year intensified campaign (2013‑2015) targeted 12 high‑risk wilayas, deploying door‑to‑door screenings, mass antibiotic distribution, and hygiene education. By 2022, WHO‑compliant surveys confirmed that active‑trachoma prevalence fell below the elimination threshold and that trachomatous‑trichiasis cases were managed, enabling the final dossier submission in 2025.

Algeria’s achievement offers a blueprint for other endemic nations. It highlights the importance of strong political will, multisectoral coordination, and robust health information systems that can track progress in real time. Continued surveillance, as recommended by WHO, will be critical to prevent re‑emergence, especially in previously endemic pockets. The success also reinforces the broader NTD agenda, showing that with sustained investment, countries can eliminate diseases that once seemed intractable, unlocking healthier, more productive societies.